MedPath

The Effect of Training on Endothelial Function, Progression of Disease,Inflammation, Heart Rate Variability and Mental Health After Percutaneous Coronary Intervention

Phase 4
Completed
Conditions
Coronary Artery Disease
Registration Number
NCT00469950
Lead Sponsor
Helse Stavanger HF
Brief Summary

The Efector study is an open, randomized and controlled trial assessing the effect of regular exercise training on endothelial function, inflammatory markers, progression of disease, heart rate variability and mental health in patients who have been successfully treated with percutaneous coronary intervention and stent implantation for angina pectoris.

Detailed Description

Pas er randomized to a 6 months training group or none training. At baseline and at 6 months patients are examined with blood tests to measure serum concentrations of inflammatory markers, a test for endothelial function, heart rate variability and a coronary angiogram. Further patients are asked to answer questionnaires concerning mental health (SF36, HADS).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Successful PCI with stent implantation,
  • Able to participate in the training program,
  • No planned further revascularisation
Exclusion Criteria
  • CAGB,
  • Inflammatory diseases other than CAD,
  • Heart failure,
  • Severe kidney failure,
  • Inability to participate in the training program

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
flow mediated dilation, serum concentrations of biomarkers, restenosis-rate/ late luminal loss, heart rate variability in SDNN6 months
Secondary Outcome Measures
NameTimeMethod
Oxygen uptake capacity (mg/kg/min), Sf36 scores6 months

Trial Locations

Locations (1)

Stavanger University Hospital

🇳🇴

Stavanger, Rogaland, Norway

© Copyright 2025. All Rights Reserved by MedPath